Magnetic resonance imaging of umbilical cord stem cells labeled with superparamagnetic iron oxide nanoparticles: effects of labelling and transplantation parameters

• Published in: Scientific reports Vol. 10; no. 1; p. 13684
• Main Authors: Ohki, Akiko, Saito, Shigeyoshi, Fukuchi, Kazuki
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 13-08-2020; Nature Publishing Group
• Subjects: 631/1647/245; 692/308/2778; Adipogenesis; Animals; Animals, Newborn; Cartilage; Cell Differentiation - drug effects; Cell Survival; Cell suspensions; Cell viability; Chondrogenesis; Dextrans - pharmacology; Humanities and Social Sciences; Iron oxides; Labeling; Magnetic Iron Oxide Nanoparticles; Magnetic resonance imaging; Magnetic Resonance Imaging - methods; Magnetite Nanoparticles; Male; Mesenchymal Stem Cells - cytology; Mesenchymal Stem Cells - drug effects; Mesenchyme; multidisciplinary; Nanoparticles; Neonates; Osteogenesis; Rats; Regenerative Medicine; Science; Science (multidisciplinary); Stem cell transplantation; Stem cells; Umbilical cord; Umbilical Cord - cytology
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-70291-9

Cell tracking with magnetic resonance imaging (MRI) is important for evaluating the biodistribution of transplanted cells. Umbilical cord-derived mesenchymal stem cells (UC-MSCs) have emerged as a promising therapeutic tool in regenerative medicine. We examined the UC-MSCs labeled with superparamagnetic (SPIO) and ultrasmall superparamagnetic iron oxide (USPIO) in terms of cell functioning and imaging efficiency in vitro and in vivo. The UC-MSCs were co-incubated with SPIO or USPIO at a concentration of 50 or 100 µg/mL of label. Viability and proliferation were assessed by Trypan blue dye exclusion and MTT assay, respectively. Differentiation (chondrogenesis, osteogenesis, and adipogenesis) was induced to examine the impact of labelling on stemness. For in vitro experiments, we used 7-T MRI to assess the T
2
values of phantoms containing various concentrations of cell suspensions. For in vivo experiments, nine neonatal rats were divided into the control, SPIO, and USPIO groups. The UC-MSCs were injected directly into the rat brains. MRI images were obtained immediately and at 7 and 14 days post injection. The UC-MSCs were successfully labeled with SPIO and USPIO after 24 h of incubation. Cell viability was not changed by labelling. Nevertheless, labelling with 100 µg/mL USPIO led to a significant decrease in proliferation. The capacity for differentiation into cartilage was influenced by 100 µg/mL of SPIO. MRI showed that labeled cells exhibited clear hypointense signals, unlike unlabeled control cells. In the USPIO-labeled cells, a significant (
P
 < 0.05) decrease in T
2
values (= improved contrast) was observed when compared with the controls and between phantoms containing the fewest and the most cells (0.5 × 10
6
versus 2.0 × 10
6
cells/mL). In vivo, the labeled cells were discernible on T
2
-weighted images at days 0, 7, and 14. The presence of SPIO and USPIO particles at day 14 was confirmed by Prussian blue staining. Microscopy also suggested that the regions occupied by the particles were not as large as the corresponding hypointense areas observed on MRI. Both labels were readily taken up by the UC-MSCs and identified well on MRI. While SPIO and USPIO provide improved results in MRI studies, care must be taken while labelling cells with high concentrations of these agents.